These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23807918)

  • 1. Chemokine systems link obesity to insulin resistance.
    Ota T
    Diabetes Metab J; 2013 Jun; 37(3):165-72. PubMed ID: 23807918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease.
    Xu L; Kitade H; Ni Y; Ota T
    Biomolecules; 2015 Jul; 5(3):1563-79. PubMed ID: 26197341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.
    Lee BC; Lee J
    Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State?
    Dommel S; Blüher M
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5: A novel player in the adipose tissue inflammation and insulin resistance?
    Ota T
    Adipocyte; 2013 Apr; 2(2):99-103. PubMed ID: 23805406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Macrophages, inflammation, adipose tissue, obesity and insulin resistance].
    Bastarrachea RA; López-Alvarenga JC; Bolado-García VE; Téllez-Mendoza J; Laviada-Molina H; Comuzzie AG
    Gac Med Mex; 2007; 143(6):505-12. PubMed ID: 18269082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune regulation of glucose and lipid metabolism.
    Ota T
    Diabetol Int; 2017 Aug; 8(3):257-267. PubMed ID: 30603331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status.
    Kitade H; Sawamoto K; Nagashimada M; Inoue H; Yamamoto Y; Sai Y; Takamura T; Yamamoto H; Miyamoto K; Ginsberg HN; Mukaida N; Kaneko S; Ota T
    Diabetes; 2012 Jul; 61(7):1680-90. PubMed ID: 22474027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity.
    Spite M; Hellmann J; Tang Y; Mathis SP; Kosuri M; Bhatnagar A; Jala VR; Haribabu B
    J Immunol; 2011 Aug; 187(4):1942-9. PubMed ID: 21742977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of adipose tissue M1/M2 macrophages in type 2 diabetes mellitus.
    Fujisaka S
    Diabetol Int; 2021 Jan; 12(1):74-79. PubMed ID: 33479582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 1 ameliorates adipose tissue inflammation and systemic insulin resistance via enhancing adipocyte mTORC2/Rictor signal.
    Zhao L; Fan M; Zhao L; Yun H; Yang Y; Wang C; Qin D
    J Cell Mol Med; 2020 Nov; 24(21):12813-12825. PubMed ID: 32979037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipocyte-Macrophage Cross-Talk in Obesity.
    Engin AB
    Adv Exp Med Biol; 2017; 960():327-343. PubMed ID: 28585206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity.
    Peng H; Zhang H; Zhu H
    Biochem Biophys Res Commun; 2016 Oct; 479(4):649-655. PubMed ID: 27693695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance.
    Finucane OM; Reynolds CM; McGillicuddy FC; Roche HM
    Proc Nutr Soc; 2012 Nov; 71(4):622-33. PubMed ID: 22914223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue recruitment of leukocytes.
    Anderson EK; Gutierrez DA; Hasty AH
    Curr Opin Lipidol; 2010 Jun; 21(3):172-7. PubMed ID: 20410821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.
    Yasui M; Tamura Y; Minami M; Higuchi S; Fujikawa R; Ikedo T; Nagata M; Arai H; Murayama T; Yokode M
    PLoS One; 2015; 10(8):e0136304. PubMed ID: 26308623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte chemotactic protein-1 and its role in insulin resistance.
    Sell H; Eckel J
    Curr Opin Lipidol; 2007 Jun; 18(3):258-62. PubMed ID: 17495598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine system and its role in obesity.
    Xue W; Fan Z; Li L; Lu J; Zhai Y; Zhao J
    J Cell Physiol; 2019 Apr; 234(4):3336-3346. PubMed ID: 30375006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?
    Sell H; Eckel J
    Proc Nutr Soc; 2009 Nov; 68(4):378-84. PubMed ID: 19698204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy.
    Yang SJ; IglayReger HB; Kadouh HC; Bodary PF
    Diabetologia; 2009 May; 52(5):972-81. PubMed ID: 19277603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.